Newsletter · · Ashutosh Agarwal

Stocks Bounce Back But the Bond Market Keeps Screaming - Daily Market Wrap - Friday, August 21, 2026

The session of Friday, August 21, 2026: stocks closed the week higher but the 30-year Treasury yield pushed near an 18-year high as booming PMI data soured bonds, a pro-crypto policy push sent Robinhood up 13.7 percent and Coinbase up 8.2 percent, and a melanoma cancer-vaccine readout lifted Moderna 8.9 percent and all of healthcare.

Daily Market Wrap

Friday, August 21, 2026: Stocks Bounce Back But the Bond Market Keeps Screaming

Wall Street shook off Thursday's scare and closed the week higher, but long-term borrowing costs near an 18-year high, a crypto-policy melt-up in the online brokers, and a cancer-vaccine surge in Moderna did the real talking.

Friday, August 21, 2026, the closing bell

  • S&P 500: 7,674.10, +0.43%
  • Dow Jones Industrial Average: 53,277.01, +517.80 (+0.98%), the day's leader
  • Nasdaq Composite: 26,180.45, +0.43%
  • Russell 2000 (small caps): 3,017.87, +0.85%
  • VIX (the "fear gauge"): 15.13, -5.5%, falling VIX means traders are paying less to insure against a drop; nerves cooled after Thursday
  • 10-year Treasury yield: 4.74%, up from 4.70%, yields rose again, and that's the whole story of the day
  • Best sector: Healthcare +1.31%. Worst: Utilities -2.27%, with Real Estate -1.36% right behind

It looked like a calm, green day on the surface. Underneath, it was a tug-of-war: stocks wanted to rally, but the bond market kept pulling in the other direction. The Dow and small-caps (the more economy-sensitive corners) led, while anything that lives or dies on interest rates got hit. As thefly summed up the close, the averages ended "the week on a high note as investors attempt to shake off a yield-driven selloff." (thefly)

Big Story 1: The economy is "booming," and that's exactly why bonds are falling

What happened. Stocks bounced, but the real action was in Treasuries. The 10-year yield climbed to 4.74% and the 30-year yield pushed near ~5.2%, its highest level since 2007. When bond yields rise, bond prices fall, and the sectors that behave like bonds got punished: Utilities sank 2.27% and Real Estate fell 1.36%, the two worst groups on the day. Rate-sensitive names led the losers' board: Sempra (-5.1%), Edison International (-4.1%), American Electric Power (-3.8%), Xcel (-3.1%).

Why it happened. The trigger was good news about the economy. S&P Global's August "flash" reading of business activity (a monthly survey of purchasing managers, released mid-month) jumped to a composite 56.0, a 52-month high (any reading above 50 signals expansion), with the services side hitting 56.8. A hotter economy means the Federal Reserve has less reason to cut interest rates and more reason to worry about inflation, so investors demand higher yields to lend the government money. Skepticism didn't help: Treasury Secretary Scott Bessent's plan to double the government's bond buybacks to at least $4 billion per operation was widely judged too small to offset a national debt now past $40 trillion. Firmer oil (WTI crude around $86–87 a barrel on Persian Gulf shipping worries) added to the inflation unease.

What people said. Chris Williamson, chief business economist at S&P Global Market Intelligence, said U.S. business activity was "booming," with output growing at its fastest pace in over four years. The bigger event is still a week away: new Fed Chair Kevin Warsh (who took over in May 2026) delivers his first keynote at the Kansas City Fed's Jackson Hole symposium next Friday, August 28. Markets are on edge because Warsh's Fed has deliberately stopped hand-holding investors with forward guidance, so his read on where long-term yields are heading will land with real force. Money markets went home pricing the Fed to hold rates in September, with a rate hike now the debate for December, not a cut.

Big Story 2: Washington hands crypto a green light, and the online brokers go vertical

What happened. The day's biggest large-cap winners were all wired to crypto trading:

  • Robinhood (HOOD) +13.7% to $108.13
  • Coinbase (COIN) +8.2% to $186.49
  • Virtu Financial (VIRT), a market-maker, +11.0% to $67.93

Why it happened. President Trump, fresh off a White House crypto summit, publicly pushed Congress to pass the pro-crypto "Clarity Act," which would set clear rules for digital assets under the SEC and CFTC. That regulatory optimism helped fuel a 20%-plus weekly run in Bitcoin, and a Bitcoin melt-up means a flood of trading volume for the platforms that handle the orders: Robinhood and Coinbase earn fees on the activity, and Virtu profits from the extra volume and volatility. It's a textbook "picks-and-shovels" trade: you don't have to bet on the coin, just on the traffic.

What people said. The rally got an extra push from the sell side: Goldman Sachs raised its price target on Robinhood to $123 from $118 while keeping a Buy rating, and pointed to the pricing of Robinhood's new Ventures Fund II and its expanding UK crypto operations as added catalysts. Note the honest caveat: there was no single hard fundamental catalyst for a +13.7% day at Robinhood; this was a policy-and-momentum melt-up, and those can reverse just as fast.

Big Story 3: A cancer-vaccine breakthrough drags all of healthcare higher

What happened. Healthcare was the best sector (+1.31%), and one name carried it: Moderna (MRNA) jumped 8.86% to $145.13. Its genomics partner Tempus AI (TEM) rose 9.1% to $72.69. The move caps a wild week: Moderna and Merck had first surged on the news, then Moderna round-tripped to a roughly -20% "sell-the-news" drop mid-week, before Friday's rebound.

Why it happened. The catalyst was positive late-stage (Phase III) data for Moderna and Merck's individualized cancer vaccine (a shot custom-built to a patient's own tumor) in melanoma, the deadliest form of skin cancer. It's a genuine, company-specific breakthrough rather than a "risk-on" beta bounce, which is why it lifted the whole sector. Tempus AI rallied in sympathy because it's positioned to be the DNA-sequencing provider for the program if the FDA approves it.

What people said. The analyst price-target revisions were staggering in size, a sign of how far this program was written off before the data. UBS analyst Michael Yee more than tripled his target to $150 from $50, noting Moderna's roughly $70 billion valuation "now implies substantial value" for the cancer program once you strip out the fading COVID business. Piper Sandler went to $167 from $77, and Jefferies to $150 from $60. On Tempus, BTIG's Mark Massaro raised his target to $80 from $70, calling the vaccine tie-up "nearly a new 'pharma services' revenue business line" for the company.

Quick Hits

  • Alibaba (BABA) -8.59% to $119.32, the day's biggest large-cap loser, still bleeding from Thursday's earnings. June-quarter adjusted earnings came in at RMB 8.52 per share versus about RMB 10.14 expected (a ~20% miss) as heavy AI spending ate into profit, even though revenue edged past estimates. CEO Eddie Wu leaned into the AI story: "Alibaba Cloud's external revenue growth accelerated to 45%, with AI-related product revenue delivering triple-digit growth for the twelfth consecutive quarter." Tellingly, most analysts raised targets anyway (JPMorgan to $210, Barclays to $200), so the stock's slide is as much about the ugly bond-market mood as the print itself.
  • Hard assets caught a bid. Copper and rare-earth miners rallied hard as investors fled into scarce physical commodities: Southern Copper +8.7%, MP Materials +9.1%, Freeport-McMoRan +7.7%. The drivers: fear of White House tariffs on imported refined copper (which has pulled 200,000+ tons into U.S. ports), five-year-tight physical copper supply, and worries about renewed Chinese rare-earth export controls.
  • Broadcom is going to the debt market, big. The chipmaker is "in talks to raise $60B of debt," per thefly, a figure worth watching given its scale. (thefly)
  • Retail earnings, mixed. BJ's Wholesale reported a Q2 beat on Friday and recovered; a day earlier Walmart beat but slipped on slower sales growth, and Flowers Foods (the Wonder Bread and Nature's Own baker) slumped on its results.
  • High-beta risk trades ran with the crypto crowd: quantum name IonQ +8.0%, uranium miner Cameco +7.2%, and gold miner Eldorado +7.2%.
  • M&A was quiet. The notable close: CoStar Group finished its $800 million cash purchase of housing-data firm Zonda. No mega-deals hit the tape.
  • The week's shape in one line: a Thursday scare over surging borrowing costs, then a Friday relief rally, but with yields still climbing into the weekend, Warsh's Jackson Hole speech next Friday is now the market's main event.